Owkin And Proscia Expand Access To AI Pre-Screening For Colorectal Cancer Patients
recent articles
Owkin’s MSIntuit® CRC v2*, a next-generation AI diagnostic aimed at transforming the detection and treatment of colorectal cancer, will be integrated into Proscia’s Concentriq® software platform, making it available as part of...
Indica Labs just announced their latest application note on AI-powered slide quality control workflows for life science and clinical applications. The SlideQC BF algorithm detects common artifacts including tissue folds, out-of-focus areas,...
From Novartis Ireland on Linked: Novartis Ireland were delighted to recently mark its Collaboration Agreement with Deciphex, a Dublin-based digital pathology company, at a specially convened panel discussion on Artificial Intelligence...
Biofidelity: Fast, simple, decentralized testing from tissue and blood using standard PCR instruments New data to be presented at AMP 2024 demonstrates best-in-class tissue and blood performance from both DNA and RNA CAMBRIDGE,...
The team at Indica Labs is excited to announce a new case study featuring the University of Washington BioRepository and Integrated Neuropathology (BRaIN) laboratory and how they achieved a 40% reduction in monthly AWS costs after taking...
Alverno is the first laboratory in the Midwest to deploy AI in routine clinical practice to improve the quality of care for its community HAMMOND, Indiana, and Boston, Massachusetts, Nov. 11, 2024 (GLOBE NEWSWIRE) -- Alverno...
